IP Library › Assignment 033175/0747
Patent Assignment
Reel/Frame 033175/0747

Assignment of Assignor's Interest

Recorded: 2014-06-10 Pages: 5
Assignor
THERAVANCE, INC.
Executed: 2014-05-31
Assignee
THERAVANCE RESPIRATORY COMPANY, LLC
901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA, USA 94080
Covered Properties (5)
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,345,060 →
Application: 10/992,927 →
Publication: US 2005/0113417
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,842,704 →
Application: 12/001,362 →
Publication: US 2008/0097105
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 7,838,535 →
Application: 12/001,363 →
Publication: US 2008/0096911
Compounds Having BETA2 Adrenergic Receptor Agonist and Muscarinic Receptor Antagonist Activity
Patent: 8,247,564 →
Application: 12/903,365 →
Publication: US 2011/0034694
Biphenyl derivatives useful for treating pulmonary disorders
Application: 60/524,234 →
Related Assignments (4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 5, 2004
From: MAMMEN, MATHAI; DUNHAM, SARAH
To: THERAVANCE, INC.
Reel/Frame 014310/0163 →
Assignment of Assignor's Interest Nov 19, 2004
From: MAMMEN, MATHAI; DUNHAM, SARAH
To: THERAVANCE, INC.
Reel/Frame 016022/0514 →
Re-Record to Remove Patent Application Number 60/524,234: Recorded on November 19, 2004 at Reel 016022/Frame 0514. Jul 5, 2005
From: MAMMEN, MATHAL; DUNHAM, SARAH
To: THERAVANCE, INC.
Reel/Frame 016598/0659 →
Assignment of Assignor's Interest Dec 22, 2020
From: THERAVANCE RESPIRATORY COMPANY, LLC
To: THERAVANCE BIOPHARMA R&D IP, LLC
Reel/Frame 054733/0898 →